NFKB1 and colitis: This study aims to investigate the therapeutic potential of BiHANs in alleviating colitis, with a focus on their antioxidant, anti-inflammatory, and microbiota-modulating effects, as well as their ability to target mitochondria and modulate the NF-κB signaling pathway (see Scheme 1).